Correlation Between Oric Pharmaceuticals and HUTCHMED DRC

Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oric Pharmaceuticals and HUTCHMED DRC, you can compare the effects of market volatilities on Oric Pharmaceuticals and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and HUTCHMED DRC.

Diversification Opportunities for Oric Pharmaceuticals and HUTCHMED DRC

0.16

Correlation Coefficient

Oric Pharmaceuticals  HUTCHMED DRC

Average diversification

The 3 months correlation between Oric and HUTCHMED is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between Oric Pharmaceuticals and HUTCHMED DRC

Given the investment horizon of 90 days Oric Pharmaceuticals is expected to generate 1.19 times more return on investment than HUTCHMED DRC. However, Oric Pharmaceuticals is 1.19 times more volatile than HUTCHMED DRC. It trades about -0.19 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.3 per unit of risk. If you would invest  959.00  in Oric Pharmaceuticals on September 23, 2024 and sell it today you would lose (138.00) from holding Oric Pharmaceuticals or give up 14.39% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Oric Pharmaceuticals  vs.  HUTCHMED DRC

Oric Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

HUTCHMED DRC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Oric Pharmaceuticals and HUTCHMED DRC

The main advantage of trading using opposite Oric Pharmaceuticals and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.

The idea behind Oric Pharmaceuticals and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.